FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087465356> ?p ?o ?g. }

• W3087465356 abstract "Favipiravir is an oral broad-spectrum inhibitor of viral RNA-dependent RNA polymerase that is approved for treatment of influenza in Japan. We conducted a prospective, randomized, open-label, multicenter trial of favipiravir for the treatment of COVID-19 at 25 hospitals across Japan. Eligible patients were adolescents and adults admitted with COVID-19 who were asymptomatic or mildly ill and had an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. Patients were randomly assigned at a 1:1 ratio to early or late favipiravir therapy (in the latter case, the same regimen starting on day 6 instead of day 1)." @default.
• W3087465356 created "2020-09-25" @default.
• W3087465356 creator A5005501569 @default.
• W3087465356 creator A5006122700 @default.
• W3087465356 creator A5006534529 @default.
• W3087465356 creator A5007649857 @default.
• W3087465356 creator A5014174633 @default.
• W3087465356 creator A5014595797 @default.
• W3087465356 creator A5016907214 @default.
• W3087465356 creator A5018154225 @default.
• W3087465356 creator A5018573172 @default.
• W3087465356 creator A5021872338 @default.
• W3087465356 creator A5022137602 @default.
• W3087465356 creator A5023823880 @default.
• W3087465356 creator A5026553342 @default.
• W3087465356 creator A5028596742 @default.
• W3087465356 creator A5030028085 @default.
• W3087465356 creator A5033747502 @default.
• W3087465356 creator A5036495238 @default.
• W3087465356 creator A5040492584 @default.
• W3087465356 creator A5040745239 @default.
• W3087465356 creator A5046971283 @default.
• W3087465356 creator A5048824271 @default.
• W3087465356 creator A5049360242 @default.
• W3087465356 creator A5050167458 @default.
• W3087465356 creator A5051231850 @default.
• W3087465356 creator A5051481287 @default.
• W3087465356 creator A5054588752 @default.
• W3087465356 creator A5059584241 @default.
• W3087465356 creator A5060722407 @default.
• W3087465356 creator A5060923113 @default.
• W3087465356 creator A5062024076 @default.
• W3087465356 creator A5063977229 @default.
• W3087465356 creator A5064864107 @default.
• W3087465356 creator A5067233448 @default.
• W3087465356 creator A5070478862 @default.
• W3087465356 creator A5073214225 @default.
• W3087465356 creator A5074318520 @default.
• W3087465356 creator A5075019101 @default.
• W3087465356 creator A5076212187 @default.
• W3087465356 creator A5078865010 @default.
• W3087465356 creator A5079714142 @default.
• W3087465356 creator A5081612422 @default.
• W3087465356 creator A5081883185 @default.
• W3087465356 creator A5086681690 @default.
• W3087465356 creator A5088044766 @default.
• W3087465356 creator A5088978814 @default.
• W3087465356 date "2020-11-17" @default.
• W3087465356 modified "2023-10-16" @default.
• W3087465356 title "A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19" @default.
• W3087465356 cites W2060514161 @default.
• W3087465356 cites W2076668534 @default.
• W3087465356 cites W2791347300 @default.
• W3087465356 cites W3008028633 @default.
• W3087465356 cites W3008666619 @default.
• W3087465356 cites W3012455685 @default.
• W3087465356 cites W3017868330 @default.
• W3087465356 cites W3034402614 @default.
• W3087465356 cites W3045391095 @default.
• W3087465356 cites W3047175026 @default.
• W3087465356 cites W3048223030 @default.
• W3087465356 cites W3048900231 @default.
• W3087465356 doi "https://doi.org/10.1128/aac.01897-20" @default.
• W3087465356 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7674035" @default.
• W3087465356 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32958718" @default.
• W3087465356 hasPublicationYear "2020" @default.
• W3087465356 type Work @default.
• W3087465356 sameAs 3087465356 @default.
• W3087465356 citedByCount "160" @default.
• W3087465356 countsByYear W30874653562020 @default.
• W3087465356 countsByYear W30874653562021 @default.
• W3087465356 countsByYear W30874653562022 @default.
• W3087465356 countsByYear W30874653562023 @default.
• W3087465356 crossrefType "journal-article" @default.
• W3087465356 hasAuthorship W3087465356A5005501569 @default.
• W3087465356 hasAuthorship W3087465356A5006122700 @default.
• W3087465356 hasAuthorship W3087465356A5006534529 @default.
• W3087465356 hasAuthorship W3087465356A5007649857 @default.
• W3087465356 hasAuthorship W3087465356A5014174633 @default.
• W3087465356 hasAuthorship W3087465356A5014595797 @default.
• W3087465356 hasAuthorship W3087465356A5016907214 @default.
• W3087465356 hasAuthorship W3087465356A5018154225 @default.
• W3087465356 hasAuthorship W3087465356A5018573172 @default.
• W3087465356 hasAuthorship W3087465356A5021872338 @default.
• W3087465356 hasAuthorship W3087465356A5022137602 @default.
• W3087465356 hasAuthorship W3087465356A5023823880 @default.
• W3087465356 hasAuthorship W3087465356A5026553342 @default.
• W3087465356 hasAuthorship W3087465356A5028596742 @default.
• W3087465356 hasAuthorship W3087465356A5030028085 @default.
• W3087465356 hasAuthorship W3087465356A5033747502 @default.
• W3087465356 hasAuthorship W3087465356A5036495238 @default.
• W3087465356 hasAuthorship W3087465356A5040492584 @default.
• W3087465356 hasAuthorship W3087465356A5040745239 @default.
• W3087465356 hasAuthorship W3087465356A5046971283 @default.
• W3087465356 hasAuthorship W3087465356A5048824271 @default.
• W3087465356 hasAuthorship W3087465356A5049360242 @default.
• W3087465356 hasAuthorship W3087465356A5050167458 @default.
• W3087465356 hasAuthorship W3087465356A5051231850 @default.
• W3087465356 hasAuthorship W3087465356A5051481287 @default.
• W3087465356 hasAuthorship W3087465356A5054588752 @default.

• next